NCT Number,Study Title,Study URL,Study Status,Conditions,Interventions,Primary Outcome Measures,Sponsor,Enrollment,Study Type,Study Design,Start Date
NCT04698226,ILM Peeling Versus Inverted Flap Technique for Treatment of Macular Hole: Near Visual Acuity Outcomes,https://clinicaltrials.gov/study/NCT04698226,RECRUITING,Macular Holes,PROCEDURE: 25-gauge pars plana vitrectomy with complete internal limiting membrane peeling and SF6 tamponade|PROCEDURE: 25-gauge pars plana vitrectomy with inverted flap technique and SF6 tamponade,"Near best corrected visual acuity on Salzburg reading desk, Near best corrected visual acuity defined as the smallest text size where reading speed is over 80 wpm or word miss rate is 1 or lower as per Salzburg reading desk exam., Month 6|Microperimetry - macular integrity, Change from baseline macular integrity score from MAIA Confocal Microperimeter Expert exam 4-2 of the study eye at month 6., Baseline and month 6|Microperimetry - avarage threshold, Change from baseline avarage threshold score from MAIA Confocal Microperimeter Expert exam 4-2 of the study eye.exam 4-2 of the study eye at month 6., Baseline and month 6|Microperimetry - fixation stability, Change from baseline fixation stability P1 and P2 from MAIA Confocal Microperimeter Expert exam 4-2 of the study eye at month 6., Baseline and month 6|Macular hole closure rate, Macular hole closure rate defined as a flattened and reattached hole rim along the whole circumference of macular hole on the OCT examination of the macular region of the study eye., Month 6",Faculty Hospital Kralovske Vinohrady,60,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2021-01-05
NCT00123279,Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy,https://clinicaltrials.gov/study/NCT00123279,COMPLETED,Vitreomacular Traction Maculopathy|Eye Diseases,DRUG: Microplasmin,"Grade of Posterior Vitreous Detachment (PVD) preoperatively and release of vitreomacular traction, Baseline, 1,2 and 3hr, 1, 3, 14, 28, 90 and 180 Days",ThromboGenics,60,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2004-12
NCT00941291,Outcome of Idiopathic Macular Hole,https://clinicaltrials.gov/study/NCT00941291,COMPLETED,Idiopathic Macular Hole,,"Long-term outcome of idiopathic macular hole surgery, 37 months",Centre Hospitalier Universitaire Dijon,135,OBSERVATIONAL,Observational Model: |Time Perspective: p,2002-01
NCT03174639,High Myopia Macular Hole and Retinal Detachment Treated With Double ILM Flaps,https://clinicaltrials.gov/study/NCT03174639,COMPLETED,High Myopia|Macular Holes|Retinal Detachment,PROCEDURE: Inverted and free ILM insertion,"Closure of macular hole, Closure of macular hole demonstrated by optical coherence tomography, 3 months",National Taiwan University Hospital,8,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-03-11
NCT06115005,Treatment of Challenging Macular Holes Using Plasma Rich in Growth Factors,https://clinicaltrials.gov/study/NCT06115005,RECRUITING,Macular Holes,BIOLOGICAL: Plasma rich in growth factors ( PRGF ),"Number of participants that revealed closure of challenging macular holes, By clinical examination and OCT, 6 months",Minia University,40,INTERVENTIONAL,"Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2022-06-01
NCT01480505,Primary Vitrectomy for the Treatment of Retinal Detachment in Highly Myopic,https://clinicaltrials.gov/study/NCT01480505,COMPLETED,"Intraocular Pressure,|Postoperative Complications",PROCEDURE: Pars plana vitrectomy with gas tamponade,"Assessing the functional and anatomical outcome of primary vitrectomy in Rhegmatogenous retinal detachment in highly myopic eyes, To assess by visual acuity measurements, fundus ophthalmoscopy and OCT scans the functional and anatomical outcome in patients with higly myopic eyes whom we performed primary vitrectomy without scleral buckling for rhegmatogenous retinal detachment (RRD)in comparison to standard surgical technics wich consist on scleral buckling and pars plana vitrectomy with fluid gas exchange.",Centre Hospitalier Universitaire Dijon,840,OBSERVATIONAL,Observational Model: |Time Perspective: p,1999-10
NCT05875909,Corneal Flap Transplantation for Macular Hole Repair of High Myopia,https://clinicaltrials.gov/study/NCT05875909,ACTIVE_NOT_RECRUITING,"Retinal Perforations|Myopia, Degenerative",PROCEDURE: corneal flap transplantation,"best-corrected visual acuity, the best-corrected visual acuity of the patients after surgery, one month to one year after surgery|complications, inflammation, infection, rejection reaction, ocular hypertension, ocular hypotension, recrudescent macular hole, parafoveal atrophy, corrugations or irregularities, choroidal neovascularisation, retinal detachment, cystoid macular oedema, reactive pigment epithelial hyperplasia, displacement, or opacification of the corneal flap, one month to one year after surgery|closure of the macular holes, closure of the macular holes observed using optical coherence tomography, one month to one year after surgery|reattachment of the retina, reattachment of the retina observed using optical coherence tomography, one month to one year after surgery",First People's Hospital of Hangzhou,30,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-02-23
NCT01083004,Brilliant Blue Versus Indocyanine Green,https://clinicaltrials.gov/study/NCT01083004,UNKNOWN,Macular Pucker|Macular Hole|Vitreoretinal Surgery,PROCEDURE: Indocyanine green|PROCEDURE: Brilliant blue arm,"Best corrected far visual acuity (ETDRS), 1 year postoperative",University of Cologne,50,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2008-01
NCT04676217,Position Related Changes in Macular Hole Morphology Before and After Surgery,https://clinicaltrials.gov/study/NCT04676217,COMPLETED,Macular Holes,PROCEDURE: Postoperative positioning advice,"Macular hole mid diameter, Micrometer, 1 day|Macular hole basal diameter, Micrometer, 1 day|Macular hole mid area, Square micrometer, 1 day|Central retinal thickness, Micrometer, 1 day",Helse Stavanger HF,40,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2021-01-01
NCT03805763,Clinical Research on the Effect of Different Extents of Internal Limiting Membrane Peeling on Macular Hole Closure and Visual Acuity,https://clinicaltrials.gov/study/NCT03805763,UNKNOWN,Macular Holes,PROCEDURE: Large extent of ILM Peeling|PROCEDURE: Small extent of ILM Peeling,"Condition of postoperative healing of macular holes, postoperative photograph of macular retina scanned by Angiography Optical Coherence Tomography(AngioOCT), 1 year|Mean change from baseline in best-corrected visual acuity (BCVA), Assessed using the ETDRS protocol, 1 year|change from baseline in foveal avascular zone (FAZ) areas and diameter, Assessed on AngioOCT, 1 year|change from baseline in the area and diameter of deteriorated circulation zone in superficial and deep retina vessels, Assessed on AngioOCT, 1 year",Wenzhou Medical University,60,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2019-02-01
NCT04904679,The Use of Amniotic Membrane or Internal Limiting Membrane for Large or Refractory Macular Holes: A Prospective Study,https://clinicaltrials.gov/study/NCT04904679,ACTIVE_NOT_RECRUITING,Macular Holes,DEVICE: Pars plana Vitrectomy with internal limiting membrane peeling,"The retinal sensibility, measured by the microperimetry, through study completion, an average of 1 year|The fixation stability, measured by the microperimetry, through study completion, an average of 1 year",Hospital Oftalmologico de Sorocaba,23,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-06-26
NCT06200727,Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases,https://clinicaltrials.gov/study/NCT06200727,ACTIVE_NOT_RECRUITING,Platelet-rich Fibrin|Macular Holes|Pterygium|Glaucoma,PROCEDURE: PRF membrane tamponade surgery in macular hole|PROCEDURE: ILM peeling in macular hole|PROCEDURE: PRF membrane grafting in pterygium|PROCEDURE: Autologous conjunctival transplantation in pterygium|PROCEDURE: autologous PRF membrane grafting in trabeculectomy for glaucoma|PROCEDURE: Amniotic membrane in trabeculectomy for glaucoma|PROCEDURE: PRF membrane grafting incorneal ulcer|PROCEDURE: Amniotic membrane in corneal ulcer,"Whether the macular hole is closed in participants with macular hole(Unit: yes/no), Using optical coherence tomography（OCT ）to see if the macular hole is healing to compare the healing rate between the PRF membrane filling group and the ILM peeling group., Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.|Whether the wound heals completely after pterygium excision in participants with pterygium(Unit: yes/no), Observation of the anterior segment of the eye using a slit lamp to determine whether the wound is healed after pterygium excision and to compare the healing rate between the PRF membrane-covered group and the autologous conjunctival-covered group., Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.|IOP in participants undergoing trabeculectomy for glaucoma(Unit: mmHg), Measurement of IOP using an IOP meter to compare the effect of IOP reduction in glaucoma treatment in the PRF membrane group and the amniotic membrane group., Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.|Whether the corneal ulcer is healing in participants with corneal ulcer(Unit: yes/no), The investigators use a slit lamp to examine the anterior segment of the eye to assess the corneal wound healing rate. The PRF membrane-covered group is compared to the control group., Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.",Lei Du,170,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-01-01
NCT02905409,Study of Surgery in Patients With Idiopathic Macular Hole,https://clinicaltrials.gov/study/NCT02905409,UNKNOWN,Idiopathic Macular Hole|Surgery,PROCEDURE: ILM peeling surgery,"Anatomical closure grades in OCT, The anatomical outcomes were defined as good closure and poor closure., 6 months|Change of anatomical closure grades in OCT, The anatomical outcomes were defined as good closure and poor closure., 1 month, 3 months, 6 months, 1 year",Peking University People's Hospital,228,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-08-31
NCT00757471,Brillant Blue Versus Indocyanine Green for Macular Hole Surgery,https://clinicaltrials.gov/study/NCT00757471,COMPLETED,Idiopathic Macular Holes,PROCEDURE: Brillant Blue|PROCEDURE: Indocyanine Green,"Macular Hole Closure Rate, 12 Months",The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery,60,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2008-08
NCT05396209,To Evaluate the Therapeutic Efficacy of Hydrated Amniotic Membrane in Promoting Closure of Refractory Macular Holes.,https://clinicaltrials.gov/study/NCT05396209,RECRUITING,Macular Holes,PROCEDURE: Hydrated Amniotic Membrane Plug|PROCEDURE: ILM filling|PROCEDURE: Conventional ILM peeling,"Rate of Anatomic closure, Rate of anatomic macular hole closure in the OCT at month 6, Month 6 post operative|Reconstruction of the foveal layered retinal structure change, Change in the reconstruction of the foveal layered retinal structure by OCT at 1, 3, and 6 months, Month 1, 3, 6 post-operative",Oriental Neurosurgery Evidence-Based-Study Team,80,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2022-06-01
NCT05897671,Foveal Sparing ILM Peeling With ILM Flap Transposition,https://clinicaltrials.gov/study/NCT05897671,COMPLETED,Full Thickness Macular Hole,OTHER: retrospective data analysis,"macular hole closure rate, postsurgical closure of macular holes is examined from routine postsurgical optical coherence tomography (OCT) imaging, up to 3 months after surgery",Vienna Institute for Research in Ocular Surgery,42,OBSERVATIONAL,Observational Model: |Time Perspective: p,2023-06-01
NCT02650739,Optical Coherence Tomography-based Positioning for Macular Hole Surgery,https://clinicaltrials.gov/study/NCT02650739,COMPLETED,Macular Hole Surgery,PROCEDURE: Macular hole surgery,"Macular hole closure, Closure of macular hole, Changes from baseline to 1, 2 months",Kyorin University,125,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-05
NCT03713268,Intraoperative OCT Guidance of Intraocular Surgery II,https://clinicaltrials.gov/study/NCT03713268,RECRUITING,Macular Holes|Epiretinal Membrane|Diabetic Retinopathy|Retinal Detachment|Retinal Disease|Preretinal Fibrosis|Cataract|Ocular Tumor|Strabismus|Healthy,DEVICE: Microscope integrated optical coherence tomography,"Retinal and/or corneal microscope integrated optical coherence tomography image capture, Ability to capture images, Year 1|Quality of retinal and/or corneal microscope integrated optical coherence tomography image capture, Quality of MIOCT images scored based on standard microanatomy and ability to detect presence or absence of ocular pathologies based on review by a masked grader., Year 1|Retinal vascular flow on optical coherence tomography angiography (OCTA) versus fluorescein angiography, Cross correlation of ability to capture vessels and vessel pathology between OCTA and fluorescein angiographic images., Year 1|Assessment of change in pattern of ocular vascular flow before and after standard clinical surgical steps., Presence or absence of change in ocular morphology in pattern of vascular flow compared to prior to surgical steps, Year 1|Assessment of change in ocular morphology before and after standard surgical steps, Presence or absence of change in ocular morphology before and after standard surgical steps, Year 1|Estimate of subretinal fluid volume before and after surgery for retinal detachment based on surgical view versus based on OCT output, Volume estimates from surgeons analyzed relative to the postoperative calculated volume from the intraoperative MIOCT, Year 1",Duke University,262,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-09-30
NCT02660320,"Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin",https://clinicaltrials.gov/study/NCT02660320,COMPLETED,Vitiligo - Macular Depigmentation,DEVICE: Dermabrasion|DEVICE: Laser placebo,"Rate of repigmentation lesions, Rate of repigmentation lesions at 3 months, at 3 months",Centre Hospitalier Universitaire de Nice,5,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2016-02
NCT05223205,Optical Coherence Tomography Angiography Characteristics of Patients With Surgically Closed Full-thickness Idiopathic Macular Holes < 600 μm With Air Versus 10% SF6 Tamponade,https://clinicaltrials.gov/study/NCT05223205,COMPLETED,Macular Holes|Optical Coherence Tomography,PROCEDURE: Air|PROCEDURE: 10% SF6 and 90% air,"Macular hole closure, 2 weeks",Medical University of Graz,40,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-07-06
NCT05757349,Analysis of Novel Positioning Sensor-assisted Postoperative Position Correction and Effective Prone Time Recorded in Patients With Different Prone Times After Macular Hole Surgery,https://clinicaltrials.gov/study/NCT05757349,RECRUITING,Idiopathic Macular Hole|Effective Prone Time,BEHAVIORAL: Face-down position time 1-day|BEHAVIORAL: Face-down position time 3-day,"Macular hole closure rate, Ratio of patients with postoperative lacunae that remained closed until the end of the follow-up time to the number of patients who reopened during the follow-up time of those who did not close after surgery, 6 month postoperatively|Effective face-down position time, Novel positioning sensor related data cloud storage platform can record and extract effective face-down position time., 1 or 3 day postoperatively",Tianjin Medical University Eye Hospital,86,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER,2022-10-01
NCT03946267,Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis.,https://clinicaltrials.gov/study/NCT03946267,COMPLETED,Macular Holes,DEVICE: Inverted inner limiting membrane flap technique for large full thickness macular holes,"Postoperative macular hole closure rate and morphology, Evaluated by swept-source OCT (Topcon DRI OCT Triton Series), twelve months|Postoperative mean corrected distance visual acuity, measured in logMAR notation using Early Treatment of Diabetic Retinopathy Study charts (CC-100XP LCD System for ETDRS Chart display), twelve months|Postoperative sizes of ellipsoid zone (EZ) and external limiting membrane (ELM) defects, Measured in micrometers by three-dimensional (3D) volumetric scan with swept-source OCT (Topcon DRI OCT Triton Series), twelve months|Thickness maps of the 1 mm central foveal thickness; second 3-mm grid including parafoveal macular area; second and the third 6-mm grid including parafoveal and perifoveal ganglion cells and inner plexiform layer; peripapillary nerve fiber layer., Measured in micrometers by auto-segmentation software (Topcon Advanced Boundary Software - TABSTM), twelve months",Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,43,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2018-01-09
NCT04883697,Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique,https://clinicaltrials.gov/study/NCT04883697,COMPLETED,Macular Holes,OTHER: vitrectomy with ILM peeling and ILM flap technique,"visual acuity, best corrected distance visual acuity, change between visual acuity 2-6 months postoperative to baseline|macular hole closure, closure of the macular hole assesed with OCT, 2-6 months postoperative",Vienna Institute for Research in Ocular Surgery,71,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-01-01
NCT01162356,Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study,https://clinicaltrials.gov/study/NCT01162356,COMPLETED,Glaucoma|Macular Pucker|Macula Hole|Vitreomacular Traction|Vitreous Opacities or Hemorrhage,,"Nerve fiber layer and macular changes after vitrectomy, To determine the incidence of nerve fiber layer (NFL) and macular changes after pars plana vitrectomy, characterize their extent and quality, and determine pre-disposing risk factors., 3 month and annually for 5 years after surgery",Vanderbilt University,45,OBSERVATIONAL,Observational Model: |Time Perspective: p,2010-07
NCT04859556,"Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study",https://clinicaltrials.gov/study/NCT04859556,COMPLETED,Vitreous Hemorrhage|Macula Hole|Epiretinal Membrane|Retinal Detachment,"DEVICE: Alcon 25Gauge, 10,000 cuts per minute Ultravit cutter|DEVICE: Alcon 25Gauge, 5,000 cuts per minute Ultravit cutter","Vitrectomy time, The time needed to remove all vitreous, 1 day",The University of Hong Kong,52,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2018-05-01
NCT02295943,Objective Evaluation of Postoperative Positioning in Macular Hole Surgery,https://clinicaltrials.gov/study/NCT02295943,TERMINATED,Macular Hole,OTHER: Positioning measuring device,"Macular hole closure, 2 weeks",Helse Stavanger HF,205,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-11
NCT03597867,PGE2 Levels in Patient Treated With NSAIDs,https://clinicaltrials.gov/study/NCT03597867,COMPLETED,Ocular Inflammation,OTHER: Placebo|DRUG: Dicloftil|DRUG: Nevanac|DRUG: Indom|DRUG: Yellox,"Vitreous NSAIDs and PGE2 levels, 3 days after topical NSAID administration",University of Trieste,104,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",2018-04-25
NCT03528122,Amniotic Membrane for Recurrent Macular Hole,https://clinicaltrials.gov/study/NCT03528122,UNKNOWN,Macula Hole|Retinal Detachment|Myopic Macular Degeneration,PROCEDURE: Recurrent opened macular hole,"Anatomical restoration of macular hole closure, Closure of the macular hole, 6 months",Minia University,20,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2018-02-01
NCT02180633,Unveiling Preclinical Idiopathic Macular Hole Formation,https://clinicaltrials.gov/study/NCT02180633,COMPLETED,Idiopathic Macular Hole,OTHER: Optical Coherence Tomography Scan,"Macular Topography, When a patient that fits into the description of either the case or the control group comes in for a routine visit, a routine optical coherence tomography scan is performed. These scans are non-invasive and common in ophthalmological visits., at 1 visit",University of Coimbra,200,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-05
NCT04535622,Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery,https://clinicaltrials.gov/study/NCT04535622,COMPLETED,Macular Holes|Retinal Detachment,BEHAVIORAL: A structured exercise,"Final pain score at back neck, shoulder, and lower back, Pain score (numerical rating scale) at back neck, shoulder, and lower back at postoperative day 3 (discharge day). Possible scores range from 0 (no pain) to 10 (worst possible pain)., postoperative day 3",Samsung Medical Center,70,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE,2020-09-03
NCT05860985,Zeiss RESIGHT Disposable Lenses Evaluation Study,https://clinicaltrials.gov/study/NCT05860985,RECRUITING,Retinal Detachment|Macular Pucker|Macular Holes|Vitreomacular Traction,DEVICE: ZEISS disposable,"Ultra Wide Field lens View Angle evaluation, Ultra Wide Field lens View Angle: scale from 1 (far more indentation) to 5 (far less indentation), during surgery|Ultra Wide Field lens Condensation evaluation, Ultra Wide Field lens Condensation: scale from 1 (far more condensation) to 5 (far less condensation), during surgery|Wide Angle lens Condensation evaluation, Wide Angle lens Condensation: scale from 1 (far more condensation ) to 5 (far less condensation), during surgery|Illumination appearance evaluation, Illumination intensity required during the surgery : scale from 1 (significantly higher) to 5 (significantly lower), during surgery|Color appearance evaluation, color appearance during the surgery : scale from 1 (far less natural colors) to 5 (far better natural colors ), during surgery",Universitaire Ziekenhuizen KU Leuven,120,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER,2023-04-11
NCT00419185,Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery,https://clinicaltrials.gov/study/NCT00419185,COMPLETED,Idiopathic Macular Hole,PROCEDURE: Delamination of the Internal limiting membrane,Primary outcome was ETDRS visual acuity (VA: snellen equivalent) at two meters 3 months after surgery.|Assignment to ICG or TB dye was performed by the Institute of Medical Biometry and Statistics of the University Luebeck per telephone immediately before surgery. Allocation to treatment arms was done with a permuted block randomization with block size 20,University of Luebeck,40,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT,2003-04
NCT01757600,Microperimetry and Optical Coherence Tomography (OCT) in Idiopathic Macular Hole,https://clinicaltrials.gov/study/NCT01757600,COMPLETED,Macular Hole,OTHER: Microperimetry,"Macular sensitivity, To describre mean retinal sensitivity in the 12 and 4 central degrees of the retina in 23 patients one-year after macular hole surgery and thus to correlate macular sensitivities and retinal anatomic features in SD-OCT, 12 months",Centre Hospitalier Universitaire Dijon,23,OBSERVATIONAL,Observational Model: |Time Perspective: p,2010-08
NCT03452748,Fourier Transformed Infrared Spectroscopy in Macular Surgery,https://clinicaltrials.gov/study/NCT03452748,COMPLETED,Epiretinal Membrane|Macular Hole,DEVICE: FTIR spectroscopy,"collagen, occurrence of different types of collagen fibres in the excised membranes, 3 months",Vienna Institute for Research in Ocular Surgery,50,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2017-01-01
NCT04527848,Comparison of Two Intraocular Gas Injection Techniques in Macula Hole Surgery,https://clinicaltrials.gov/study/NCT04527848,COMPLETED,Macular Holes,DRUG: small amount of undiluted C3F8,"Gas duration, duration of intraocular gas, up to 60 days|macula hole closure, closure of the macular hole after the primary surgical procedure, 26 weeks",Universidade Federal de Pernambuco,48,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2016-05-10
NCT05828251,Full Thickness Macular Hole; Should it be Handled Subacutely?,https://clinicaltrials.gov/study/NCT05828251,RECRUITING,Full Thickness Macular Hole,PROCEDURE: Vitrectomy (Sequential phakoemulsification and vitrectomy)|PROCEDURE: Combined phako-vitrectomy|PROCEDURE: Phako (Sequential phakoemulsification and vitrectomy),"Visual acuity, Best corrected visual acuity measured with ETDRS, the ETDRS scoe will be converted to LogMAR, 12 months after vitrectomy","Rigshospitalet, Denmark",56,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2023-04-30
NCT01471912,Elongation of Foveal Tissue After Macular Hole Surgery,https://clinicaltrials.gov/study/NCT01471912,COMPLETED,Macular Holes,PROCEDURE: pars plana vitrectomy and fluid gas exchange,"Changes in the inter-outer plexiform layer distance, the spectral domain optical coherence tomography scannings were performed at first postoperative visit, 1 month, 2 months, and 6 months after macular hole surgery. The inter-outer plexiform layer distance was measured based on optical coherence tomography images at defined time points, first postoperative visit, 1 month, 2 months, and 6 months after macular hole surgery|Changes in best-corrected visual acuity, Best-corrected visual acuity was measured using early treatment diabetic retinopathy study chart at defined time points, first postoperative visit, 2 months, and 6 months after macular hole surgery|Changes in degree of metamorphopsia, The degree of metamorphopsia was measured using Metamorphopsia-chart at defined time points, first postoperative visit, 2 months, and 6 months after macular hole surgery|Degree of percent asymmetric elongation on the same plane, The horizontal percent asymmetry was calculated as (nasal distance - temporal distance)/(nasal distance + temporal distance). The vertical percent asymmetry was also calculated as (superior distance - inferior distance)/ (superior distance + inferior distance., at 6 months postoperative|Degree of horizontal-vertical percent asymmetry, The percent asymmetry was calculated as (horizontal inter-outer plexiform layer distance - vertical inter-outer plexiform layer distance)/(horizontal inter-outer plexiform layer distance + vertical inter-outer plexiform layer distance)., at 6 months postoperative",Samsung Medical Center,31,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2009-09
NCT05494242,Single Superior ILM/ERM Flap for the FTMH.,https://clinicaltrials.gov/study/NCT05494242,COMPLETED,Ophthalmopathy,OTHER: Surgical intervention,"Anatomical outcome, OCT, The fourth weeks post-operatively",Omer Othman Abdullah,5,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2022-09-01
NCT03701542,The Application of M-charts and Microperimetry for the Assessment of Visual Function in Patients After Vitrectomy Due to the Full Thickness Macular Hole.,https://clinicaltrials.gov/study/NCT03701542,COMPLETED,Macular Holes|Microperymetry|Vitrectomy|M-charts,DIAGNOSTIC_TEST: Microperymetry|DIAGNOSTIC_TEST: M-charts,"The best-corrected visual acuity (BCVA), Acuity is a measure of visual performance. The eye exam seeks to find the prescription that will provide the best corrected visual performance achievable, 1 to 6 months|Amsler test, The Amsler grid, consisting of evenly spaced horizontal and vertical lines, has been widely used since 1947 to test the metamorphopsia., 1 to 6 months|Central retinal thickness, Quantitative thickness measurements derived from the ""fast macular scan"" algorithm report retinal thickness at several locations including the center point, central subfield, and 4 inner and 4 outer zones of the macula., 1 to 6 months",Medical University of Lublin,22,OBSERVATIONAL,Observational Model: |Time Perspective: p,2016-01-01
NCT02011165,An Objective Evaluation of Postoperative Positioning in Macular Hole Surgery,https://clinicaltrials.gov/study/NCT02011165,COMPLETED,Macular Hole,PROCEDURE: Positioning measuring device,"Time in supine sleeping position, Two days",Helse Stavanger HF,43,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-10
NCT03383731,A Study of a New Surgical Treatment of Macular Hole Retinal Detachment in High Myopia,https://clinicaltrials.gov/study/NCT03383731,UNKNOWN,Macular Holes|Retinal Detachment|High Myopia,PROCEDURE: Group 1|PROCEDURE: Group 2,"Macular hole closure rate, Fundus examination combined with optical coherence tomography (OCT) are performed 3 months after surgery., 3 months after operation","Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",38,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2017-04-07
NCT01889251,A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion,https://clinicaltrials.gov/study/NCT01889251,COMPLETED,Symptomatic Vitreomacular Adhesion,DRUG: Ocriplasmin|DRUG: Sham injection,"Proportion of Subjects With Non-Surgical Resolution of Vitreomacular Adhesion (VMA), VMA (adhesion of the vitreous gel to the retina in an abnormally strong manner) was determined by masked Central Reading Center (CRC) Spectral Domain Optical Coherence Tomography (SD-OCT) evaluation. Only one eye (study eye) was analyzed. Proportion of subjects is reported as a percentage., Day 28",Alcon Research,251,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2013-07
NCT02073266,Impact of C3F8 or SF6 Use and Length of Face-down Positioning (7 vs 14 Days Respectively) in Macular Hole Surgery,https://clinicaltrials.gov/study/NCT02073266,COMPLETED,Macular Holes|Visual Acuity Gain|Cataract|Complications,"PROCEDURE: Macular hole surgery using a 25 G pars plana vitrectomy, ILM peeling, fluid-air exchange followed by air-gas exchange with SF6 or C3F8.","Macular hole closure and visual acuity gain, The primary purpose of the study was to compare the macular hole closure and visual acuity gain following vitrectomy using SF6 gas tamponade with 7 days of face-down positioning versus C3F8 gas tamponade with 14 days of face-down positioning., 1 year",CHU de Quebec-Universite Laval,59,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2010-01
NCT03287648,Simultaneous OCT and B-FAF in Eyes With Alteration of the Foveal Contour,https://clinicaltrials.gov/study/NCT03287648,RECRUITING,Lamellar Macular Hole|Lamellar Macular Pseudohole,DIAGNOSTIC_TEST: optical coherence tomography and blue-fundus autofluorescence,"Relationship between OCT and B-FAF findings, Measurements of the diameters of the holes expressed in microns, on OCT and B-FAF images respectively, will be collected. The topographic correlation between the area of increased B-FAF signal and the corresponding area on OCT, will be examined., 6 months",University of Molise,20,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-06-01
NCT05171621,Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery,https://clinicaltrials.gov/study/NCT05171621,COMPLETED,Ophthalmologic Complication|Epiretinal Membrane|Metamorphopsia|Macular Holes,,"Compare the responses of the McAllinden and Metamorphopsia Questionnaire, analysing changes to responses in the 2 questionnaires pre and post surgery, pre surgery and 2 - 3 months post surgery",Hayley Westwood,50,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-10-16
NCT01381965,Foveal Cone Outer Segment Resumption to Predict Visual Recovery After Macular Hole Surgery,https://clinicaltrials.gov/study/NCT01381965,COMPLETED,Macular Holes,PROCEDURE: Vitreous surgery for macular hole,"Visual acuity, Preoperative, postoperative 1, 3, 6, 9, 12 months, one year",Kyorin University,72,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2008-03
NCT03465865,Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition,https://clinicaltrials.gov/study/NCT03465865,UNKNOWN,Macular Hole,DEVICE: optical coherence tomography,"OCT, macular hole closure is assessed with optical coherence tomography, 5 minutes",Vienna Institute for Research in Ocular Surgery,20,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-09-01
NCT05083650,Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis,https://clinicaltrials.gov/study/NCT05083650,UNKNOWN,Macular Holes,PROCEDURE: Macular hole closure with amniotic membrane with/without internal limiting membrane peeling,"% of macular hole clousure measured with OCT, Closure of the macular hole by optical coherence tomography, 6 months",Instituto de Oftalmología Fundación Conde de Valenciana,16,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT",2021-03-10
NCT02528045,Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy,https://clinicaltrials.gov/study/NCT02528045,COMPLETED,Macular Hole Retinal Detachment|Myopic Traction Maculopathy,PROCEDURE: Vitrectomy with scleral shortening,"Visual acuity before and after surgery, Comparison with logarithm of Minimum Angle of Resolution (logMAR) vision, 6 months",Kyorin University,16,OBSERVATIONAL,Observational Model: |Time Perspective: p,2012-06
NCT06079593,GaslEss Macular Hole Surgery,https://clinicaltrials.gov/study/NCT06079593,NOT_YET_RECRUITING,Macular Holes,PROCEDURE: Gasless Macular hole surgery|PROCEDURE: Standard Macular hole surgery,"Feasibility: Screen failure, Proportion of those screened who are randomised, 36 months|Feasibility: Recruitment rate, Recruitment rate (participants per site per month), 36 months|Feasibility: Participant retention, Proportion reaching month 6 milestone visit, 6 months|Feasibility: Cross-over, Proportion converting to standard vitrectomy with gas, due to inability to seal the FTMH, or detection of peripheral retinal breaks, 36 months",King's College Hospital NHS Trust,60,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER,2024-01-01
NCT04459949,Comparative Study of Sharkskin Versus Grieshaber Forceps During ILM Peeling,https://clinicaltrials.gov/study/NCT04459949,UNKNOWN,Epiretinal Membrane|Macular Holes,DEVICE: Sharkskin|DEVICE: Grieshaber,"Surgical time, During surgery",Wills Eye,100,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2020-07-06
NCT05269563,Double Flap Technique for Macular Hole,https://clinicaltrials.gov/study/NCT05269563,COMPLETED,Macular Holes,OTHER: Surgical intervention,"Ocular coherence tomography, The closure of the hole can be assessed clearly, The fourth week post-operatively",Omer Othman Abdullah,20,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-01-01
NCT00408720,Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies,https://clinicaltrials.gov/study/NCT00408720,COMPLETED,Macular Hole|RPE Detachment|Epiretinal Membrane|Posterior Vitreous Detachment,,,The New York Eye & Ear Infirmary,25,OBSERVATIONAL,Observational Model: |Time Perspective: p,2006-10
NCT04957459,The Correlation of Preoperative Measurement Parameter on the Predicting of Visual Outcomes Among Patients With Idiopathic Macular Holes,https://clinicaltrials.gov/study/NCT04957459,UNKNOWN,Macular Holes,OTHER: No intervention,"Macular hole status, macular hole status (open, flat open or closed), at 1 month after surgery|MLD of macular hole, Calculation of minimum liner diameter of macular hole with optical coherence tomography angiography, Before surgery|BD of macular hole, Calculation of base diameter of macular hole with optical coherence tomography angiography, Before surgery|Choroidal hypertransmission width of macular hole, Calculation of Choroidal hypertransmission width of macular hole with optical coherence tomography angiography, Before surgery|Horizontal ellipsoid band missing diameter of macular hole, Calculation of Horizontal ellipsoid band missing diameter of macular hole with optical coherence tomography angiography, Before surgery|Baseline best-corrected visual acuity, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, Before surgery|best-corrected visual acuity at 1 month, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, at 1 month after surgery|best-corrected visual acuity at 2 months, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, at 2 months after surgery|best-corrected visual acuity at 3 months, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, at 3 months after surgery|best-corrected visual acuity at 4 months, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, at 4 months after surgery|best-corrected visual acuity at 5 months, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, at 5 months after surgery|best-corrected visual acuity at 6 months, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, at 6 months after surgery|FAZ area of macular hole, Calculation of foveal avascular zone (FAZ) area of macular hole with optical coherence tomography angiography, Before surgery|FAZ area of macular hole at 1 month, Calculation of foveal avascular zone (FAZ) area of macular hole with optical coherence tomography angiography, at 1 month after surgery|FAZ area of macular hole at 2 months, Calculation of foveal avascular zone (FAZ) area of macular hole with optical coherence tomography angiography, at 2 months after surgery|FAZ area of macular hole at 3 months, Calculation of foveal avascular zone (FAZ) area of macular hole with optical coherence tomography angiography, at 3 months after surgery|FAZ area of macular hole at 4 months, Calculation of foveal avascular zone (FAZ) area of macular hole with optical coherence tomography angiography, at 4 months after surgery|FAZ area of macular hole at 5 months, Calculation of foveal avascular zone (FAZ) area of macular hole with optical coherence tomography angiography, at 5 months after surgery|FAZ area of macular hole at 6 months, Calculation of foveal avascular zone (FAZ) area of macular hole with optical coherence tomography angiography, at 6 months after surgery|CRT of macular hole, Calculation of central retinal thickness(CRT) of macular hole with optical coherence tomography angiography, Before surgery|CRT of macular hole at 1 month, Calculation of central retinal thickness(CRT) of macular hole with optical coherence tomography angiography, at 1 month after surgery|CRT of macular hole at 2 months, Calculation of central retinal thickness(CRT) of macular hole with optical coherence tomography angiography, at 2 months after surgery|CRT of macular hole at 3 months, Calculation of central retinal thickness(CRT) of macular hole with optical coherence tomography angiography, at 3 months after surgery|CRT of macular hole at 4 months, Calculation of central retinal thickness(CRT) of macular hole with optical coherence tomography angiography, at 4 months after surgery|CRT of macular hole at 5 months, Calculation of central retinal thickness(CRT) of macular hole with optical coherence tomography angiography, at 5 months after surgery|CRT of macular hole at 6 months, Calculation of central retinal thickness(CRT) of macular hole with optical coherence tomography angiography, at 6 months after surgery","Second Affiliated Hospital, School of Medicine, Zhejiang University",60,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-01-01
NCT03799575,Internal Limiting Membrane and Macular Hole,https://clinicaltrials.gov/study/NCT03799575,UNKNOWN,C11.768.740,BEHAVIORAL: Transmission Electron Microscopy analysis,"Fibrosis in vitreal sides of Internal Limiting Membranes, Fibrilliary process between two vitreal sides of Internal Limiting Membranes in contact, after incubation in enriched medium, 12 months","Hospital de Santa Maria, Portugal",10,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-01-02
NCT03437759,MSC-Exos Promote Healing of MHs,https://clinicaltrials.gov/study/NCT03437759,UNKNOWN,Macular Holes,BIOLOGICAL: exosomes derived from mesenchymal stem cells (MSC-Exo),"Macular holes closure, Minimum linear diameter (MLD) of the hole measured by OCT, baseline to 24 weeks post-surgery",Tianjin Medical University,44,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2017-03-01
NCT01680068,Air Tamponade in Macular Hole Surgery,https://clinicaltrials.gov/study/NCT01680068,COMPLETED,Macular Hole,PROCEDURE: Pars plana vitrectomy and postoperative air tamponade,"Closure rate of macular hole, 1 month after enrollment",Helse Stavanger HF,20,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2012-09
NCT02584062,Clinical Observation of Technologic Application of No-touch Fluid-air Exchange in Surgery of Idiopathic Macula Hole,https://clinicaltrials.gov/study/NCT02584062,COMPLETED,Idiopathic Macula Hole,PROCEDURE: no-touch fluid-air exchange|PROCEDURE: vitrectomy metrectomy and internal membrane peeling and gas tamponed,"the closure rate of Macular hole, the closure rate of macular hole through OCT, one month|the closure rate of Macular hole, the closure rate of Macular hole, three month|the closure rate of Macular hole, the closure rate of Macular hole, six month",Tianjin Medical University Eye Hospital,40,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2016-01-25
NCT02896972,Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes,https://clinicaltrials.gov/study/NCT02896972,COMPLETED,Macular Hole Retinal Detachment,PROCEDURE: Vitrectomy,"Visual acuity before and after surgery, Changes from baseline to 1, 3, 6 months",Kyorin University,32,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2012-04
NCT01974310,Postoperative Positioning After Surgery for Macular Holes,https://clinicaltrials.gov/study/NCT01974310,COMPLETED,Macular Holes,PROCEDURE: Vitrectomy & Intraocular gas fill|PROCEDURE: Postoperative face-down positioning,"Macular hole closure rate, Macular hole closure rate assessed by optical coherence tomography, 3 months","Glostrup University Hospital, Copenhagen",68,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-10
NCT04135638,Inverted ILM-flap Techniques Variants for Macular Hole Surgery: Outcomes Comparison,https://clinicaltrials.gov/study/NCT04135638,UNKNOWN,Macular Holes,PROCEDURE: Cover Group|PROCEDURE: Fill Group,"Visual outcome linked to ""Cover"" and ""Fill"" procedures, To report :

- Best Corrected Visual Acuity (BCVA expressed in logMAR)

of idiopathic Macular Holes (MH) randomized to Cover Group (CG) or Fill Group (FG) of the Inverted Internal Limiting Membrane (ILM) flap surgical procedure., five months|Anatomical outcome linked to ""Cover"" and ""Fill"" procedures, To report:

- closure rate (μm)

of idiopathic Macular Holes (MH) randomized to Cover Group (CG) or Fill Group (FG) of the Inverted Internal Limiting Membrane (ILM) flap surgical procedure, five months",University of Molise,28,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER,2019-11-01
NCT05086588,Safety and Efficacy Evaluation of Two Different Brilliant Blue G Dyes as Staining Agent in Vitreo Retinal Surgery.,https://clinicaltrials.gov/study/NCT05086588,COMPLETED,Macular Holes|Epiretinal Membrane,,"Staining Ability of ILM, Staining of ILM is assed after dye injection with choosing Excellent/Good/ Needs to Improve by surgeon, Intra-Operatively|Change from Baseline to 1 Month, 3 Months and 6 Months in CMT (Central Macular Thickness), CMT (Central Macular Thickness) in micron meters is accessed with ocular coherence tomography, Pre-Op, 1 Month, 3 Month and 6 Month|Change from Baseline to 1 Month, 3 Months and 6 Months in TMV ( Total Macular Volume), TMV ( Total Macular Volume) in cubic millimeter is accessed with ocular coherence tomography, Pre-Op, 1 Month, 3 Month and 6 Month|Change from Baseline to 1 Month, 3 Months and 6 Months in SFCT (sub foveal choroidal thickness), SFCT (sub foveal choroidal thickness) in cubic meter is accessed with ocular coherence tomography, Pre-Op, 1 Month, 3 Month and 6 Month|Change from Baseline to 1 Month, 3 Months and 6 Months in Intra-retinal cuff pathology segmentation, Intra-retinal cuff pathology segmentation in micron meter is accessed with ocular coherence tomography, Pre-Op, 1 Month, 3 Month and 6 Month|Change from Baseline to 1 Month, 3 Months and 6 Months in RNFL Thickness (Retinal Nerve Fiber Layer), RNFL Thickness (Retinal Nerve Fiber Layer) in micron meter is accessed with ocular coherence tomography, Pre-Op, 1 Month, 3 Month and 6 Month|Change from Baseline to 1 Month, 3 Months and 6 Months in Hole diameter, Hole diameter in micron meter is accessed with ocular coherence tomography, Pre-Op, 1 Month, 3 Month and 6 Month|Change from Baseline to 1 Month, 3 Months and 6 Months in Optic Disc situation, Optic Disc situation is accessed with ocular coherence tomography, Pre-Op, 1 Month, 3 Month and 6 Month|Change from Baseline to 6 Month in Foveal perfusion characteristics, Foveal perfusion characteristics are assed with FFA(Fundus Fluorescein Angiography), Pre-Op, 6 Month|Change from Baseline to 6 Month in Vascular evaluation, Vascular evaluation is assed with FFA(Fundus Fluorescein Angiography), Pre-Op, 6 Month|Change from Baseline to 6 Month in Fundus auto fluorescence (FAF), Fundus auto fluorescence (FAF) are assed with FFA(Fundus Fluorescein Angiography), Pre-Op, 6 Month|Multifocal ERG, During multifocal ERG testing, the patient views a rapidly changing sequence on the monitor. The resulting electrical activity is recorded by an electrode, then amplified and analyzed. During stimulation the hexagons on the screen independently change every 13 milliseconds. They all follow the same pseudorandom sequence, with each hexagon starting at a slightly different position in this sequence. Using a cross-correlation technique, the software determines the retinal response from each of the 103 segments of the retina., Pre-op, 1 Month, 3 Month and 6 Month|Overview of Adverse Events, An AE could be any unfavorable and unintended symptom, sign, disease or condition, or test abnormality whether or not considered related to the investigational product. A serious adverse event (SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. Treatment-emergent AEs (TEAE): AEs that developed/worsened during the 'on treatment period' (from first dose of study device until the end of study period). Category ""AE"" included participant with both serious and non-serious AE., Through study completion, an average of 6 Months",Dr. Lutfi Kirdar Kartal Training and Research Hospital,86,OBSERVATIONAL,Observational Model: |Time Perspective: p,2018-04-04
NCT01228188,Inverted ILM Repositioning as Treatment for Full Thickness Macular Holes,https://clinicaltrials.gov/study/NCT01228188,UNKNOWN,Macular Holes,PROCEDURE: Inverted ILM Repositioning,"Best-corrected visual acuity (BCVA), postoperative macular hole closure type, BCVA for ETDRS chart (converted to logMAR) and postoperative macular hole closure type assessed by OCT: elevated-open, flat-open and flat-closed., up to 1 week before surgery|Best-corrected visual acuity (BCVA), postoperative macular hole closure type, BCVA for ETDRS chart (converted to logMAR) and postoperative macular hole closure type assessed by OCT: elevated-open, flat-open and flat-closed., 2 weeks postoperatively ( plus or minus 1 week)|Best-corrected visual acuity (BCVA), postoperative macular hole closure type, BCVA for ETDRS chart (converted to logMAR) and postoperative macular hole closure type assessed by OCT: elevated-open, flat-open and flat-closed., 4 weeks postoperatively ( plus or minus 1 week)|Best-corrected visual acuity (BCVA), postoperative macular hole closure type, BCVA for ETDRS chart (converted to logMAR) and postoperative macular hole closure type assessed by OCT: elevated-open, flat-open and flat-closed., 6 weeks postoperatively ( plus or minus 1 week)|Best-corrected visual acuity (BCVA), postoperative macular hole closure type, BCVA for ETDRS chart (converted to logMAR) and postoperative macular hole closure type assessed by OCT: elevated-open, flat-open and flat-closed., 12 weeks postoperatively ( plus or minus 1 week)|Best-corrected visual acuity (BCVA), postoperative macular hole closure type, BCVA for ETDRS chart (converted to logMAR) and postoperative macular hole closure type assessed by OCT: elevated-open, flat-open and flat-closed., 24 weeks postoperatively ( plus or minus 1 week)|Best-corrected visual acuity (BCVA), postoperative macular hole closure type, BCVA for ETDRS chart (converted to logMAR) and postoperative macular hole closure type assessed by OCT: elevated-open, flat-open and flat-closed., 48 weeks postoperatively ( plus or minus 1 week)",Military Institute od Medicine National Research Institute,25,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2010-08
NCT01121965,Early Vitrectomy for Impending Macular Hole,https://clinicaltrials.gov/study/NCT01121965,UNKNOWN,Retinal Perforation,PROCEDURE: Pars plana vitrectomy with ILM peeling,"Best Corrected Visual acuity, 48 weeks",Seoul Retina Investigator Group,60,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2009-11
NCT02628262,Fundus Autofluorescence After Macular Hole Surgery,https://clinicaltrials.gov/study/NCT02628262,COMPLETED,Macular Hole,PROCEDURE: Vitrectomy with internal limiting membrane removal and gas tamponade,"Visual acuity before and after surgery, Vision, Changes from baseline to 1,3, 6 months",Makoto Inoue,27,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-04
NCT01692938,Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO,https://clinicaltrials.gov/study/NCT01692938,COMPLETED,Age-Related Macular Degeneration|Geographic Atrophy|Diabetic Retinopathy|Macular Edema|Retinal Vein Occlusion|Central Serous Retinopathy|Pattern Dystrophy of Macula|Epiretinal Membrane|Macular Hole,,"Standard Deviation and Mean Test Results of Normal and With Pathology Participants Taken by 3 Different Operator-device Configurations, A precision study was conducted that used 3 devices (each with a different operator). Each device was used to measure 4 normal subjects and 4 subjects with relevant eye pathology, with a total of 24 subject eyes (12 normal, 12 with pathology) measured across all three devices. For each subject, one eye was evaluated using 3 tests with repositioning at the start of each test. Test results were given in decibels which is the unit used in microperimetry testing. Overall mean and standard deviation in decibels were calculated for the two groups: normal and with pathology., 1 Month|Repeatability of Microperimetry Tests in Normal and With Pathology Participants Based on 3 Microperimetry Tests Taken for Each Participant for a Given Operator-device Combination., A precision study was conducted that used 3 devices (each with a different operator). Each device was used to measure 4 normal subjects and 4 subjects with relevant eye pathology, with a total of 24 subject eyes (12 normal, 12 with pathology) measured across all three devices. Test results were given in decibels as that is the standard measurement in microperimetry testing. For each subject, one eye was evaluated using 3 microperimetry tests with repositioning at the start of each test. Overall Repeatability SD and Repeatability SD Limit were calculated for the two groups: normal and with pathology., 1 Month","Optos, PLC",32,OBSERVATIONAL,Observational Model: |Time Perspective: p,2012-10
NCT02010138,Extent of ILM Removal and Its Impact on Outcomes of MH Surgery,https://clinicaltrials.gov/study/NCT02010138,COMPLETED,Macular Holes,PROCEDURE: small-extent peeling|PROCEDURE: large-extent peeling,"Degree of foveal elongation, postoperative 6months",Samsung Medical Center,65,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2013-07
NCT00286637,Novel Diagnostics for Ocular Structure,https://clinicaltrials.gov/study/NCT00286637,RECRUITING,Glaucoma|Macular Disease,,"Novel Diagnostics for Ocular Structure, The purpose of this research is to evaluate novel technologies for the assessment of ocular structure and function, including the scanning device called Optical Coherence Tomography (OCT). We will test the OCT and other devices in their ability to image diseases of the eye and also compare the measurements made with OCT to those of other imaging and visual field devices approved by the Food and Drug Administration (FDA). OCT may be useful for the early diagnosis and monitoring of a variety of types of eye diseases, 5 years",NYU Langone Health,2767,OBSERVATIONAL,Observational Model: |Time Perspective: p,1995-01
NCT01306487,Observation of Recovery of Foveal Cone Microstructures After Macular Hole Surgery,https://clinicaltrials.gov/study/NCT01306487,COMPLETED,Macular Holes,PROCEDURE: Vitrectomy,"Foveal microstructure determined by optical coherence tomography, The integrity of the microstructures of the foveal photoreceptors; the inner segment/outer segment (IS/OS) junction, the external limiting membrane (ELM), and the cone outer segment tips (COST) line were determined by spectral domain optical coherence tomography., Preoperative and postoperative 1, 3, 6, 9, 12 months",Kyorin University,58,OBSERVATIONAL,Observational Model: |Time Perspective: p,2008-03
NCT03433547,Effects of Macular Buckle Versus Vitrectomy on Macular Hole and Macular Detachment in Highly Myopic Eyes,https://clinicaltrials.gov/study/NCT03433547,COMPLETED,Macular Holes|High Myopia|Macular Detachment,PROCEDURE: Buckle|PROCEDURE: Vitrectomy|OTHER: Limbal paracentesis|OTHER: Gas injection|OTHER: Peeling internal limiting membrane|OTHER: Gas tamponade,"Retinal re-attachment rate, Successful rate of reattachment of macular retina after surgery, 1 month",Sun Yat-sen University,50,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-01-30
NCT03244007,Evaluation of Retinal Microstructure Detected With Intraoperative Optical Coherence Tomography During Vitrectomy,https://clinicaltrials.gov/study/NCT03244007,COMPLETED,Macular Disease,PROCEDURE: Vitrectomy,"Recovery of microstructure, 6 months",Kyorin University,100,OBSERVATIONAL,Observational Model: |Time Perspective: p,2015-12-12
NCT00286507,Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study,https://clinicaltrials.gov/study/NCT00286507,COMPLETED,Stage 2 or 3 Full Thickness Macular Hole,"PROCEDURE: Vitrectomy, post hyaloid detachment and gas injection with or without ILM peel.","The primary outcome of the study is the mean difference between treatment groups in the Early Treatment Diabetic Retinopathy Study (ETDRS) distance visual acuity score., 6 months post surgery",University of Aberdeen,141,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2005-07
NCT03020459,Internal Limiting Membrane Peeling-reposition to Treat Idiopathic Macular Holes,https://clinicaltrials.gov/study/NCT03020459,COMPLETED,Macular Hole|Surgery,PROCEDURE: peeling-reposition|PROCEDURE: peeling|DRUG: Brilliant Blue G|OTHER: postoperative posture|DEVICE: Constellation 23-gauge vitrectomy system,"Best corrected visual acuity(BCVA), Change from baseline BCVA at 6 months after operation, examined with snellen chart., Pre-operation and 6 months after operation","Xinhua Hospital, Shanghai Jiao Tong University School of Medicine",30,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2017-01-01
NCT01083056,Observational Study - ILM Peeling,https://clinicaltrials.gov/study/NCT01083056,COMPLETED,Epimacular Gliosis|Macular Hole,,"BCVA, 6 months after ILM peeling",University Hospital Tuebingen,10,OBSERVATIONAL,Observational Model: |Time Perspective: p,2010-03
NCT00190190,Internal Limiting Membrane Peeling for Large Macular Holes,https://clinicaltrials.gov/study/NCT00190190,COMPLETED,Macular Hole,PROCEDURE: With Peeling of Limiting the Intern of the Retina|PROCEDURE: Internal limiting membrane peeling,"percentage of success (anatomical closing, confirmed by OCT) at third postoperative month, in both groups, at 3 months",Assistance Publique - Hôpitaux de Paris,80,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2005-01
NCT06063005,Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole,https://clinicaltrials.gov/study/NCT06063005,RECRUITING,Macular Holes,PROCEDURE: Translocation ILM Flap|PROCEDURE: ILM Peeling,"Best Corrected Visual Acuity, The best corrected visual acuity indicates the best visual acuity with proper refractive correction., 1 week, 1 month, 3 months, 1 years, 2 years after the operation","Xinhua Hospital, Shanghai Jiao Tong University School of Medicine",76,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2022-07-01
NCT01820520,Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery,https://clinicaltrials.gov/study/NCT01820520,UNKNOWN,Macular Hole|Epiretinal Membrane,DRUG: brilliant blue G,"Thickness of ganglion cell layer - inner plexiform layer measured by optical coherence tomography, Average thickness of ganglion cell layer - inner plexiform layer measured by spectral domain optical coherence tomography, 6 months|Amplitude of pattern reversal electroretinogram, Amplitude of pattern reversal electroretinogram (in microvolts), 6 months|Amplitude of b-wave of multifocal electroretinogram, Measurement of the amplitude of the b-wave of multifocal electroretinogram, 6 months",Asociación para Evitar la Ceguera en México,30,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-01
NCT02946372,Evaluation of a New Surgical Technique for Macular Hole Which Was Not Closed After a Previous Surgery,https://clinicaltrials.gov/study/NCT02946372,COMPLETED,Retinal Perforations,PROCEDURE: internal limiting membrane transplantation (ILMT),"Presence of the internal limiting membrane transposed into foveal region, 8 weeks after surgery",Groupe Hospitalier de la Region de Mulhouse et Sud Alsace,16,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-11
NCT00190164,Alleviated Positioning for Small Macular Holes,https://clinicaltrials.gov/study/NCT00190164,COMPLETED,Macular Hole,PROCEDURE: Macular hole surgery with alleviated positioning|PROCEDURE: Macular hole surgery with no alleviated positioning,"Frequency of the successes defined by anatomical closure at third postoperative month., during the 3 months",Assistance Publique - Hôpitaux de Paris,69,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2005-08
NCT02423161,PIONEER: Intraoperative and Perioperative OCT Study,https://clinicaltrials.gov/study/NCT02423161,COMPLETED,Retinal Detachment|Epiretinal Membrane|Macular Hole|Fuchs Endothelial Dystrophy,,"Feasibility of intraoperative OCT, Defined as percentage of cases where OCT was successfully able to be obtained during surgery, 3 years",The Cleveland Clinic,750,OBSERVATIONAL,Observational Model: |Time Perspective: p,2011-08
NCT05113212,Damages From Macular Grasping During Vitrectomy Comparing Traditional and 3D Microscope,https://clinicaltrials.gov/study/NCT05113212,COMPLETED,Comparison of 3D Visualization and Microscope for VR Surgery,DEVICE: Macular surgery with NGENUITY surgical display system|DEVICE: Macular surgery with standard operating microscope,"SANFL detection, Post-surgical analysis of SANFL (Swelling of the Arcuate Nerve Fiber Layer) measured on infrared, blue auto-fluorescence images and OCT images of peripapillary region, 2 weeks after surgery","Anna Rita Daniele, MD",64,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2021-11-19
NCT02748421,Optical Coherence Tomography - Rescan During Dissection of Macular Membranes,https://clinicaltrials.gov/study/NCT02748421,UNKNOWN,Macular Hole|Epiretinal Membrane|Traction Syndrome Vitreomacular|Proliferative Vitreoretinopathy,PROCEDURE: Lumera Microscope with OCT RESCAN|PROCEDURE: Conventional Microscope,"Assess optimal maneuvers in macular membrane dissection, by a questionnaire responded by surgeons (no difficulty, some difficulty, very difficulty), Day 0 (surgical day)",Federal University of São Paulo,30,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: ",2016-05
NCT04116892,Comparative Analysis of Large Macular Hole Surgeries,https://clinicaltrials.gov/study/NCT04116892,UNKNOWN,Macular Holes,PROCEDURE: the Cover group|PROCEDURE: the Fill group|PROCEDURE: the peeling group,"MH status, MH status (open, flat open or closed), at 3 months after surgery|IS/OS line interruption width, IS/OS line interruption width were gauged with spectral-domain optical coherence tomography, at 3 months after surgery|Change from Baseline IS/OS line interruption width at 3 months, IS/OS line interruption width were gauged with spectral-domain optical coherence tomography, at 3 months after surgery|Baseline best-corrected visual acuity, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, at 3 months after surgery|Change from Baseline best-corrected visual acuity at 3 months, best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis, at 3 months after surgery|visual function, visual function were gauged with national eye institute visual function questionnaire-25((NEI VFQ-25), at 3 months after surgery|Change from Baseline visual function at 3 months, visual function were gauged with national eye institute visual function questionnaire-25((NEI VFQ-25), at 3 months after surgery","Second Affiliated Hospital, School of Medicine, Zhejiang University",100,INTERVENTIONAL,"Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2019-05-01
NCT03572725,Air Tamponade and Non-supine Positioning in Macular Hole Surgery.,https://clinicaltrials.gov/study/NCT03572725,COMPLETED,Macular Holes,PROCEDURE: Gas tamponade|PROCEDURE: Air tamponade,"Macular hole closure verified on OCT, Macular hole closure verified on OCT after one macular hole intervention, 2 - 8 weeks postoperatively",Helse Stavanger HF,150,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-09-26
NCT00537992,Blue-Blocking IOLs in Combined Surgery,https://clinicaltrials.gov/study/NCT00537992,COMPLETED,Epiretinal Membranes|Macular Holes|Cataract,PROCEDURE: combined surgery,intraoperative conditions for the surgeon (scaled questionnaire) and patients´ outcome,The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery,60,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2004-10
NCT03927430,Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen,https://clinicaltrials.gov/study/NCT03927430,COMPLETED,Epiretinal Membrane|Macular Holes|Age Related Macular Degeneration,PROCEDURE: pars plana vitrectomy with membrane peeling,"number of patients with CNV, number of patients with CNV (choroidal neovascularization) development, last visit, in common 6 months postoperatively",Klinikum Chemnitz gGmbH,40,OBSERVATIONAL,Observational Model: |Time Perspective: p,2019-01-01
NCT03888625,Compare the Healing Process of Idiopathic Macular Hole With Different Surgical Techniques,https://clinicaltrials.gov/study/NCT03888625,UNKNOWN,Macular Holes,PROCEDURE: Conventional ILM Peeling|PROCEDURE: Inverted ILM Peeling,"Rate of Anatomic closure, Rate of anatomic macular hole closure in the OCT at month 6, Month 6 post operative",Federal University of São Paulo,60,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-06-15
NCT01509092,Comparative Study Between Early Vitrectomy and Observation for Spontaneous Closure of Traumatic Macular Hole,https://clinicaltrials.gov/study/NCT01509092,COMPLETED,Trauma|Macular Hole,PROCEDURE: vitrectomy surgery,"macular hole closure rate, 6 month after injury",Peking University Third Hospital,44,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2012-01
NCT06211907,Small Macular Holes Treated With Air,https://clinicaltrials.gov/study/NCT06211907,NOT_YET_RECRUITING,Macular Holes,DEVICE: Postoperative intraocular tamponade,"Macular hole closure after single surgery, Closure verified on OCT, 4 weeks",Helse Stavanger HF,132,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2024-02-01
NCT04011007,Comparison of Vitrectomy Without Internal Limiting Membrane Peeling Versus Inverted ILM Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes,https://clinicaltrials.gov/study/NCT04011007,COMPLETED,Macular Holes|Retina Detachment,PROCEDURE: vitrectomy with or without inverted ILM flap technique,"visual acuity at one year, 12 months",University of Alexandria,40,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-01-01
NCT05710458,"Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter",https://clinicaltrials.gov/study/NCT05710458,COMPLETED,Vitrectomy|Epiretinal Membrane|Macular Hole|Vitreous Hemorrhage|Retinal Detachment,"DEVICE: 25 gauge 20,000 cpm Hypervit Dual Blade|DEVICE: 25 gauge 10,000 cpm Ultravit Vitrectomy Cutter","Duration of Core vitrectomy, Measurement of core vitrectomy duration by Constellation Vision System, intraoperative (From the moment probe enter into the eye till performing the air/fluid exchange to complete the vitrectomy)",The University of Hong Kong,72,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2021-07-01
NCT03646695,ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study,https://clinicaltrials.gov/study/NCT03646695,COMPLETED,Macular Holes,PROCEDURE: ILM flap transposition|PROCEDURE: ILM peeling,"closure of the macular hole, closure of the macular hole will be assessed, 3 months",Vienna Institute for Research in Ocular Surgery,20,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-09-01
NCT04346095,Oral Sedation in Vitreoretinal Surgery,https://clinicaltrials.gov/study/NCT04346095,UNKNOWN,Macular Holes|Intraocular Lens Opacification|Vitrectomy|Vitreous Hemorrhage|Retinal Detachment|Epiretinal Membrane|Vitreous Detachment|Intraocular Lens Dislocation,DRUG: Oral Sedatives with or Without Analgesia|DRUG: Intravenous Sedatives with or Without Analgesia,"Patient satisfaction: scale, The patient will complete a survey at the one-day post-operative appointment. The survey consists of statements regarding the surgical procedure and experience with a scale of 1 to 6 demonstrating the patient's agreement or disagreement with the statement. Additional questions regarding the surgery and not using the 1 to 6 model will also be asked in the same survey. There will be 14 questions in the 1-6 scale portion of the survey and 4 additional questions. After all questions have been answered, the scaled questions will be analyzed for an average score out of 6 per patient. Additional questions will be analyzed by percentage of each answer. The scaled questions will be used to determine the non-inferiority of the experimental treatment. Additional questions will not be included in the non-inferiority analysis but results will be included in the study., A patient satisfaction survey will be completed at the one-day post operative appointment.","Rocky Vista University, LLC",80,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2020-06
NCT03376776,Epiretinal Proliferation in Eyes With Full Thickness Macular Hole,https://clinicaltrials.gov/study/NCT03376776,COMPLETED,Macular Disease,PROCEDURE: Vitrectomy,"Recovery of foveal microstructure, 6 months",Kyorin University,390,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-03
NCT00555269,Membrane Blue Versus Infracyanine Green,https://clinicaltrials.gov/study/NCT00555269,COMPLETED,Macular Pucker|Macular Hole,,"Visual acuity, macular thickness and peripheral visual field",The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery,30,OBSERVATIONAL,Observational Model: |Time Perspective: p,2004-10
NCT00737074,Macular Hole in Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT00737074,COMPLETED,Macular Hole|Proliferative Diabetic Retinopathy,,"Final opening or closure of macular hole, Six months",National Taiwan University Hospital,23,OBSERVATIONAL,Observational Model: |Time Perspective: p,2002-01
NCT05747144,Multimodal Imaging in Vitreo-retinal Surgery and Macular Dystrophies,https://clinicaltrials.gov/study/NCT05747144,RECRUITING,Macular Holes|Epiretinal Membrane|Retinal Detachment|Macular Dystrophies,DIAGNOSTIC_TEST: Biometry|DIAGNOSTIC_TEST: Retinography (Color) + Autofluorescence (AF)|DIAGNOSTIC_TEST: OCT B-scan and OCT angiography (OCTA)|DIAGNOSTIC_TEST: Microperimetry|DIAGNOSTIC_TEST: Electrophysiological exams,"Predictivity of morphological-functional radiomic data, Rate of predictivity of morphological-functional radiomic data to establish the grade of recovery in the post-operative period by means of an artificial intelligence (AI) machine learning model., 3 years",Fondazione Policlinico Universitario Agostino Gemelli IRCCS,100,OBSERVATIONAL,Observational Model: |Time Perspective: p,2021-01-15
NCT01229657,Evaluation of Anatomic and Visual Outcomes of Initially Closed Macular Holes,https://clinicaltrials.gov/study/NCT01229657,COMPLETED,Macular Holes,,,Sun Yat-sen University,79,OBSERVATIONAL,Observational Model: |Time Perspective: p,2010-03
NCT04655781,Internal Limiting Membrane Peeling on Retinal Displacement,https://clinicaltrials.gov/study/NCT04655781,COMPLETED,Internal Limiting Membrane Peeling,PROCEDURE: idiopathic macular hole (MH) surgery,"T-OD, measurement of temporal vessel to optic disc, preoperation to postoperative 6 months",The First Affiliated Hospital with Nanjing Medical University,20,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2017-01-01
NCT01959776,Asymmetrical Recovery of Cone Outer Segment Tips and Foveal Displacement After Macular Hole Surgery,https://clinicaltrials.gov/study/NCT01959776,COMPLETED,Macular Hole,PROCEDURE: Vitrectomy,"Optical coherence tomography, Anatomical evaluation detected with optical coherence tomography after surgical intervention, one year",Kyorin University,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: |Primary Purpose: TREATMENT,2009-07
NCT04404296,"Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter",https://clinicaltrials.gov/study/NCT04404296,UNKNOWN,Vitrectomy|Retinal Detachment|Vitreous Hemorrhage|Macular Holes|Epiretinal Membrane|Dislocated Intraocular Lens Into Vitreous|Retained Lens Fragments,"DEVICE: 25-gauge, bevel-tip, 20000 cut per minute pars plana vitrectomy","Operative time: Total, From insertion of first trocar to removal of last trocar, measured in seconds using stopwatch, 6 months",Peregrine Eye and Laser Institute,50,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2021-04-01
NCT01257698,Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy,https://clinicaltrials.gov/study/NCT01257698,COMPLETED,Macular Hole|Retinal Detachment,DRUG: Dorzolamide 2%-timolol 0.5% topical eyedrops,"Duration of Intraocular Gas, Patients will self-monitor gas bubble duration and will receive weekly phone calls by the study coordinator until gas disappearance is confirmed., Up to 4 weeks",Mid Atlantic Retina,21,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2010-02
NCT02028481,Air Tamponade in Macular Holes < 400 μm,https://clinicaltrials.gov/study/NCT02028481,COMPLETED,Macular Holes,PROCEDURE: Postoperative air tamponade,"Closure rate of macular hole, 1 month after enrollment",Helse Stavanger HF,13,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-12
NCT02930369,Effects of Different Area of Internal Limiting Membrane Peeling (ILM) Peeling on Anatomical Outcomes in Macular Hole Surgery,https://clinicaltrials.gov/study/NCT02930369,COMPLETED,Macular Hole,PROCEDURE: ILM peeling surgery,"Anatomical closure grades in OCT, 1 year",Peking University People's Hospital,128,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2015-06
NCT03677869,Effects of Pneumatic Vitreolysis on Macular Hole,https://clinicaltrials.gov/study/NCT03677869,COMPLETED,Vitreomacular Traction (VMT)|Full-thickness Macular Holes (MH),DEVICE: Intraocular gas (C3F8),"Proportion of Eyes With Macular Hole Closure of Inner Retinal Layers Without Rescue Vitrectomy, at 8 weeks",Jaeb Center for Health Research,36,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2018-11-14
NCT05287269,Ocular Coherence Tomography During Cataract Assessment,https://clinicaltrials.gov/study/NCT05287269,COMPLETED,Cataract Senile|Macula Hole|Epiretinal Membrane|Age Related Macular Degeneration|Vitreomacular Traction,DIAGNOSTIC_TEST: Ocular Coherence Tomography,"Incidence of occult macular pathologies in the eye referred for cataract surgery, Comparison of slitlamp biomicroscopy fundus finding with ocular coherence tomography (OCT) scan of the macula, During the cataract assessment clinic",Brighton and Sussex University Hospitals NHS Trust,626,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-11-02
NCT04683276,ILM Inverted Flap Size in Macular Hole,https://clinicaltrials.gov/study/NCT04683276,COMPLETED,Idiopathic Macular Hole,PROCEDURE: pars plana vitrectomy with ILM inverted flap,"rate of macular hole closure, defined as the proportion of the eyes with complete MH closure based on SD-OCT findings, 6 months",Mansoura University,42,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2019-02-01
NCT03618498,Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment,https://clinicaltrials.gov/study/NCT03618498,COMPLETED,Retinal Detachment,PROCEDURE: ILM flaps insertion techniques or free ILM flaps.,"Wilcoxon Sign-Rank test, A statistical comparison of average of two dependent samples, Baseline, 12 months.",Changhua Christian Hospital,10,INTERVENTIONAL,Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2018-03-07
NCT01687829,Macular Hole Surgery With and Without Internal Limiting Membrane Peeling：A Systematic Review and Meta-analysis,https://clinicaltrials.gov/study/NCT01687829,UNKNOWN,Macular Holes,,"Anatomic Success rate, Anatomic success defined as a closed hole without a visible edge or a flat hole without a rim of subretinal fluid., 12 months|Functional Success Rate, Functional Success defined as an improvement of 2 or more Snellen BCVA., 12 month",Yifan Feng,400,OBSERVATIONAL,Observational Model: |Time Perspective: p,2013-01
NCT02691429,Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans,https://clinicaltrials.gov/study/NCT02691429,COMPLETED,Epiretinal Membrane|Macular Hole|Diabetic Retinopathy,OTHER: Acai dye 10%,"ocular inflammation, signs of ocular inflammation, up to 30 days",Federal University of São Paulo,24,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER",2016-02
NCT01069029,Combined Versus Successive Macular Hole and Cataract Surgery,https://clinicaltrials.gov/study/NCT01069029,COMPLETED,Macular Hole|Visual Acuity,,"Post surgical procedure assessment of Visual acuity, 6 and 12 months post surgery",Centre Hospitalier Universitaire Dijon,120,OBSERVATIONAL,Observational Model: |Time Perspective: p,2006-01
NCT02203929,Preoperative Progression of Macular Holes,https://clinicaltrials.gov/study/NCT02203929,COMPLETED,Macular Holes,,"Macular hole Progression, Serial optical coherence tomography (OCT) measurements in the preoperative period. The size of macular hole is determined by measuring the macular hole minimal linear diameter (µm).

Size and stage of macular hole is determined at primary evaluation at tertiary ophthalmic center. Initial scan is followed by pre-vitrectomy scan if patient is pseudophakic. Initial OCT scan is followed by pre- and postcataract as well as pre-vitrectomy OCT scan if patient is pseudophakic., 3 months preoperative","Glostrup University Hospital, Copenhagen",37,OBSERVATIONAL,Observational Model: |Time Perspective: p,2014-06
NCT01020760,Protocol for RCT of Posturing in Phacovitrectomy for Full Thickness Macular Hole (FTMH),https://clinicaltrials.gov/study/NCT01020760,COMPLETED,Full Thickness Macular Hole,BEHAVIORAL: Face down posture,"estimate variance and effect size order to inform power calculations for further studies., one year",NHS Greater Glasgow and Clyde,30,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2008-09
NCT01226160,Pilot Randomised Controlled Trial of Posturing Following Surgery for Full-thickness Macular Hole,https://clinicaltrials.gov/study/NCT01226160,COMPLETED,Full Thickness Macular Hole,PROCEDURE: Postoperative face-down posturing|PROCEDURE: Postoperative non-posturing group,"Anatomical closure of the macula hole assessed 6 weeks following surgery by ocular coherence tomography., 6 weeks",Moorfields Eye Hospital NHS Foundation Trust,30,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2005-01
NCT00302328,Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes,https://clinicaltrials.gov/study/NCT00302328,COMPLETED,Idiopathic Macular Hole,PROCEDURE: macular hole operation,"Visual Acuity (ETDRS Letters), Visual acuity measured as the number of ETDRS letters at last follow-up, Visual acuity at 12 months","Glostrup University Hospital, Copenhagen",78,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2005-08
NCT05191628,Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole,https://clinicaltrials.gov/study/NCT05191628,TERMINATED,Macular Holes|Retinal Detachment,BIOLOGICAL: Visio-AMTRIX,"Closure of recurrent macular hole, Macular hole closure evaluated by optical coherence tomography (OCT), 6 months",TBF Genie Tissulaire,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2020-06-10
NCT01969929,Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy,https://clinicaltrials.gov/study/NCT01969929,UNKNOWN,Macular Hole|Macular Pucker,PROCEDURE: 20G Vitrectomy|PROCEDURE: 23G vitrectomy,"Alteration of aqueous flare between preoperative and 3-week-postoperative time point, 3 weeks",University of Cologne,100,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE",2013-10
NCT02895594,Outcome of Surgery for Idiopathic Macular Holes,https://clinicaltrials.gov/study/NCT02895594,COMPLETED,Idiopathic Macular Hole,,"Primary closure of macular hole after repair surgery, within six months after surgery",Fondation Ophtalmologique Adolphe de Rothschild,59,OBSERVATIONAL,Observational Model: |Time Perspective: p,2012-01
NCT05517473,Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains,https://clinicaltrials.gov/study/NCT05517473,COMPLETED,Macular Holes|Macular Pucker|Vitreomacular Traction,,"visualization of membranes, visualization of membranes stained based on binary subjective evaluation., intraoperative (surgery day)",Universitaire Ziekenhuizen KU Leuven,100,OBSERVATIONAL,Observational Model: |Time Perspective: p,2022-07-05
NCT05494229,Autologous Blood for Full-thickness Macular Hole,https://clinicaltrials.gov/study/NCT05494229,TERMINATED,Ophthalmopathy,OTHER: Pars-plana vitrectomy,"Anatomical outcome, OCT, The fourth week post-operatively",Omer Othman Abdullah,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-09-01
NCT00333060,Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal,https://clinicaltrials.gov/study/NCT00333060,TERMINATED,Epiretinal Membrane|Macular Hole,DRUG: OT-551 ophthalmic solution,change in visual acuity|change in lens opacity,Othera Pharmaceuticals,164,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: ",2005-11
NCT04723160,Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph,https://clinicaltrials.gov/study/NCT04723160,COMPLETED,Diabetic Retinopathy|Retinal Vein Occlusion|Retinal Artery Occlusion|Central Serous Chorioretinopathy|Pathologic Myopia|Retinitis Pigmentosa|Epiretinal Membrane|Macular Holes|Nonexudative Age-related Macular Degeneration|Exudative Age Related Macular Degeneration|Suspect Glaucoma|Optic Atrophy|Retinal Detachment,DIAGNOSTIC_TEST: Software assisted imaging diagnosis,"consistent rate of diagnoses, Formula for calculation: consistent rate of diagnoses=number of images with consistent diagnosis/ total number of images × 100%.

Method: the diagnoses from the test group and the control group were compared with diagnoses from the gold standard. For each image, if one or more diagnoses were consistent with those of the gold standard, which means at least one label existed in the intersection of diagnoses from the test group(or the control group)and those from the gold standard, it would be classified as ""image with consistent diagnosis"". Otherwise, it would be classified as ""image without consistent diagnosis"". After above-mentioned steps, the investigators had obtained the number of images with consistent diagnosis in each group. As images with 1-2 labels account for the majority in actual work, the investigators stipulated that each image in both groups could be marked with 3 labels at most in case of invalid improvement in consistent rate owing to multiple selections., through study completion, an average of 1 year",Visionary Intelligence Ltd.,748,OBSERVATIONAL,Observational Model: |Time Perspective: p,2020-08-10
NCT06194760,Evaluation of Vitrectomy With ILM Peeling in Myopic Macular Hole With Only Posterior Retinal Detachment,https://clinicaltrials.gov/study/NCT06194760,ACTIVE_NOT_RECRUITING,Retinal Detachment,PROCEDURE: Vitrectomy with ILM peeling,"Closure of macular hole, It is a subjective outcome measured by Optical coherence tomography and by clinical slit lamb examination, 6 months post operative|BCVA, It is a measure of the visual acuity, which will be measured by LogMar, baseline|BCVA, It is a measure of the visual acuity, which will be measured by LogMar, 6 months postoperative|BCVA, It is a measure of the visual acuity, which will be measured by LogMar, 12 months postoperative",Al-Azhar University,13,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2022-01-01
NCT03287102,Macular Hole Surgery With Temporal Inverted Internal Limiting Membrane Flap (MARTIAL),https://clinicaltrials.gov/study/NCT03287102,UNKNOWN,Macula Hole,PROCEDURE: Macular hole surgery,"Number of dimples on optical coherence tomography, Incidence of DONFL appearance, 3 months after surgery","Central Hospital, Nancy, France",130,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2018-02-01
NCT01627977,"Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy",https://clinicaltrials.gov/study/NCT01627977,COMPLETED,Epiretinal Membrane|Macular Hole|Proliferative Diabetic Retinopathy,"OTHER: Dye of Lutein, Zeaxanthin and Brilliant Blue","Visibility of the membrane after injection of the dye, The visibility of the membrane after injection of the dye should be graduated by the physician as Bad, OR Fair, OR Good, OR Very Good, during the surgery",Federal University of São Paulo,18,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2012-10
NCT03332758,"Inflammasomes in Cell Death in FTMH, ERM, and RRD",https://clinicaltrials.gov/study/NCT03332758,COMPLETED,Retinal Detachment|Full Thickness Macular Hole|Epiretinal Membrane,PROCEDURE: Pars plana vitrectomy|PROCEDURE: External drainage,"Presence of inflammasomes and their active products, Presence of inflammasomes and their active products in patients with retinal detachment treated with vitrectomy or external drainage, macular holes treated with vitrectomy, and epiretinal membranes treated with vitrectomy, Day of surgery","Allen C. Ho, MD",41,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-09-08
NCT02644694,PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy,https://clinicaltrials.gov/study/NCT02644694,COMPLETED,Vitrectomy,DRUG: Dexamethasone Phosphate Ophthalmic Solution,"Concentration of dexamethasone, Vitreous humor samples will be analyzed for dexamethasone concentrations, Day 1|Concentration of dexamethasone phosphate, Vitreous humor samples will be analyzed for dexamethasone phosphate concentrations, Day 1","Eyegate Pharmaceuticals, Inc.",10,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-03
NCT02683694,Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases,https://clinicaltrials.gov/study/NCT02683694,COMPLETED,Macular Diseases,DEVICE: iOCT,"peeling without staining, number of patients that could be peeled without use of a dye, intraoperative (10-15 minutes)",Vienna Institute for Research in Ocular Surgery,81,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2015-02
NCT01266746,Optical Coherence Tomography in Gas-filled Eyes,https://clinicaltrials.gov/study/NCT01266746,COMPLETED,Macular Hole,PROCEDURE: Vitreous surgery,"macular hole closure detected by spectral domain optical coherence tomography, The maular hole closure in eyes with intravitreal gas is detected by spectral domain optical coherence tomography, Change from preoperative status up to postoperative day 30.",Kyorin University,37,OBSERVATIONAL,Observational Model: |Time Perspective: p,2009-04
NCT03917602,Human Amniotic Membrane Plug for Large Macular Holes,https://clinicaltrials.gov/study/NCT03917602,COMPLETED,Macular Holes,PROCEDURE: human amniotic membrane plug with vitrectomy,"closure of the macular hole, closure of the macular hole as shown by optical coherence tomography, at the 6 month follow up visit",University of Alexandria,15,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2019-05-11
NCT04212624,Clinical Research of Human Retinal Pigment Epithelial (HuRPE) Cell Injection on Atrophy of High Myopia Macular Area,https://clinicaltrials.gov/study/NCT04212624,UNKNOWN,Degenerative Myopia With Macular Hole,OTHER: Human retinal pigment epithelial (HuRPE) cell injection,"Number of subjects with Local and systemic adverse events, Descriptive analysis of frequency and types of adverse events experienced by each subject during the study period., six months following transplantation","Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2019-12
NCT00927628,Macular Hole Reopening,https://clinicaltrials.gov/study/NCT00927628,COMPLETED,Vitrectomy,PROCEDURE: Vitrectomy,"A complete clinical examination including BCVA, slit-lamp biomicroscopy with a contact lens, indirect ophthalmoscopy, and fundus photography were performed post surgery., Patients were examined preoperatively and postoperatively on day one, and at two weeks, and one, three, and six months. Thereafter, they were examined every three to six months.",Shinjo Ophthalmologic Institute,831,OBSERVATIONAL,Observational Model: |Time Perspective: p,1990-10
NCT02894424,Effect of the Membrane Blue Dual® Dye on the Retinal Sensitivity in Macular Hole Surgery,https://clinicaltrials.gov/study/NCT02894424,COMPLETED,Macular Hole Surgery,,"change in retinal sensitivity, change from baseline sensitivity at 1 month after macular hole surgery, change from baseline sensitivity at 1 month after macular hole surgery",Fondation Ophtalmologique Adolphe de Rothschild,34,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-02-23
NCT04498624,Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes,https://clinicaltrials.gov/study/NCT04498624,UNKNOWN,Full Thickness Macular Hole,PROCEDURE: inverted flap|PROCEDURE: peeling internal limiting membrane (ILM),"Microperimetry retinal sensitivity, Difference of microperimetry retinal sensitivity after primary vitrectomy for idiopathic full thickness macular holes with inverted flap technique versus internal limiting membrane (ILM) peeling technique, 3 months","University of Turin, Italy",40,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2020-05-01
NCT01429441,Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole,https://clinicaltrials.gov/study/NCT01429441,COMPLETED,Vitreomacular Adhesion Including Macular Hole,DRUG: Ocriplasmin|OTHER: Sham injection,"Proportion of Subjects With Pharmacological Vitreomacular Adhesion (VMA) / (Vitreomacular Traction [VMT]) Resolution at Day 28, Pharmacological VMA resolution without anatomical defect, based on SD-OCT and determined by the masked central reading center (CRC), with post-resolution vitrectomy considered as a failure. Missing data were imputed using the last observation carried forward (LOCF) method., Day 28",ThromboGenics,220,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2011-10
NCT02001701,Intravitreal Gas for Vitreomacular Adhesion,https://clinicaltrials.gov/study/NCT02001701,WITHDRAWN,Vitreomacular Adhesion,PROCEDURE: Intravitreal Injection of sulfahexafluoride gas,"Proportion of patients with resolution of vitreomacular adhesion at Day 28, Day 28",Northern California Retina Vitreous Associates,0,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-11
NCT00485199,Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole,https://clinicaltrials.gov/study/NCT00485199,COMPLETED,Retinal Detachment,PROCEDURE: Pneumatic Retinopexy|PROCEDURE: Vitrectomy with Gas,"BCVA improvement,anatomic success, 1,3,6,9, and 12 months after treatment",Peking University,231,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT,2005-01
NCT03525899,Macular Hole After Diabetic Vitrectomy,https://clinicaltrials.gov/study/NCT03525899,COMPLETED,Proliferative Diabetic Retinopathy|Macular Holes,PROCEDURE: Pars plana vitrectomy,"Time to macular hole closure, Evaluation by optical coherence tomography, OCT was performed monthly after operation, until MH closure was achieved, up yo 1 year",National Taiwan University Hospital,7,OBSERVATIONAL,Observational Model: |Time Perspective: p,2017-11-01
NCT02081170,The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes,https://clinicaltrials.gov/study/NCT02081170,UNKNOWN,"Macular Hole With High Myopia (Spherical Equivalent ≤ -6.0 Diopters) or,|Large Size Macular Hole (Diameter > 600 Microns) or|Recurred or Failed Macular Hole From Previous Surgery|or Chronic Macular Hole (Symptom Duration > 6 Months)",PROCEDURE: Autologous platelet concentrate,"macular hole closure, 6 months",Samsung Medical Center,16,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-12
NCT02067013,Analysis of Aqueous and Vitreous Humor,https://clinicaltrials.gov/study/NCT02067013,UNKNOWN,Proliferative Diabetic Retinopathy|Macular Degeneration|Macular Hole|Neovascular Glaucoma,DRUG: Ranibizumab|OTHER: No Ranibizumab,"Cytokine Levels, Growth factor, cytokine, chemokine , and ranibizumab (if applicable) concentration in aqueous and vitreous samples collected during pars plana vitrectomy, Collected at Baseline",California Retina Consultants,45,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2015-07
NCT06000111,Duration of Face Down Positioning for Full-Thickness Macular Hole Repair,https://clinicaltrials.gov/study/NCT06000111,RECRUITING,Macular Holes,BEHAVIORAL: 3 Days of face-down positioning|BEHAVIORAL: 7 Days of face-down positioning,"Recruitment Rate, This investigation's primary objective will be focused on assessing feasibility. One primary outcome will be to evaluate the recruitment rate of this study., The recruitment rate will be calculated during the recruitment period.|Retention Rate, This investigation's primary objective will be focused on assessing feasibility. One primary outcome will be to evaluate the retention rate of this study., The retention rate will be calculated at 3-months post-operatively.|Completion Rate, This investigation's primary objective will be focused on assessing feasibility. One primary outcome will be to evaluate the completion rate of this study., The completion rate will be calculated at 3-months post-operatively.|Recruitment Time, This investigation's primary objective will be focused on assessing feasibility. One primary outcome will be to evaluate the recruitment time for this study., The recruitment time will be calculated during the recruitment period.",St. Joseph's Healthcare Hamilton,40,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2023-11-21
NCT02423213,DISCOVER Study: Microscope-integrated Intraoperative OCT Study,https://clinicaltrials.gov/study/NCT02423213,RECRUITING,Retinal Diseases|Fuchs Endothelial Dystrophy|Macular Hole|Epiretinal Membrane|Retinal Detachment,,"To assess feasibility of microscope-integrated intraoperative OCT, Feasibility will be assessed as the percentage of cases where OCT images were successfully obtained with a microscope-integrated system, 3 years",The Cleveland Clinic,3000,OBSERVATIONAL,Observational Model: |Time Perspective: p,2014-01
